NCT01160419 - Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2014

Conditions

Gastric Cancer

Interventions

DRUG

Docetaxel 50 mg/m2, 1-hour-Infusion, day 1

50 mg/m2, 1-hour-Infusion, day 1

DRUG

Oxaliplatin 85 mg/m², 2-hour-Infusion, day 1

85 mg/m², 2-hour-Infusion, day 1

DRUG

Folinic acid 200 mg/m², 1-2-hour-Infusion, day 1

200 mg/m², 1-2-hour-Infusion, day 1

DRUG

5-FU 2600 mg/m², 24-hour-Infusion, day 1

2600 mg/m², 24-hour-Infusion, day 1

Trial Locations (1)

University of Munich, Klinikum Grosshadern, Munich